254 related articles for article (PubMed ID: 32736781)
1. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
2. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
[TBL] [Abstract][Full Text] [Related]
3. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
Mantha S; Tallman MS; Soff GA
Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
[TBL] [Abstract][Full Text] [Related]
5. Coagulopathy of acute promyelocytic leukemia.
Falanga A; Barbui T
Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
[TBL] [Abstract][Full Text] [Related]
6. The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
[TBL] [Abstract][Full Text] [Related]
7. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
Korístek Z; Zák P
Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of acute promyelocytic leukemia in a patient with prosthetic heart valves: a case report and review of the literature.
Haghighat S; Rezvani A; Mokhtari M
J Med Case Rep; 2021 May; 15(1):260. PubMed ID: 33941263
[TBL] [Abstract][Full Text] [Related]
9. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid.
Singh C; Karunakaran P; Yanamandra U; Jindal N; Kumar SR; Saini N; Jandial A; Jain A; Lad D; Prakash G; Khadwal A; Kumar N; Naseem S; Ahluwalia J; Varma N; Varma S; Malhotra P
Leuk Res; 2023 Nov; 134():107392. PubMed ID: 37774447
[TBL] [Abstract][Full Text] [Related]
11. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
12. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
16. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom.
Tallman MS; Brenner B; Serna Jde L; Dombret H; Falanga A; Kwaan HC; Liebman H; Raffoux E; Rickles FR
Leuk Res; 2005 Mar; 29(3):347-51. PubMed ID: 15661272
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
Infante JB; Esteves GV; Raposo J; de Lacerda JF
Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
Rodeghiero F; Castaman G
Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]